The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes-Reference-Cited by-同舟云学术

The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

Published:2010-05 Issue:3 Volume:6 Page:257-264
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Beckett Laurel A.¹,Harvey Danielle J.¹,Gamst Anthony²,Donohue Michael²,Kornak John³⁴,Zhang Hao¹,Kuo Julie H.¹,

Affiliation:

1. Department of Public Health SciencesUniversity of CaliforniaDavisCAUSA

2. Division of Biostatistics and BioinformaticsUniversity of CaliforniaSan DiegoCAUSA

3. Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoCAUSA

4. Department of Epidemiology and BiostatisticsUniversity of CaliforniaSan FranciscoCAUSA

Funder

National Institutes of Health

National Institute on Aging

National Institute of Biomedical Imaging and Bioengineering

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2010.03.002

Reference28 articles.

1. Mixed brain pathologies account for most dementia cases in community-dwelling older persons

2. Assessing Outcomes in Alzheimer Disease

3. Neuropathology of Cognitively Normal Elderly

4. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

5. Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging Initiative;Alzheimer's & Dementia;2024-09-06

2. Skin-contact Wearable Electrochemical Biosensing Tools: a perspective for the Well-being of Neurological Patients;TrAC Trends in Analytical Chemistry;2024-09

3. Contributions of the ADNI Biostatistics Core;Alzheimer's & Dementia;2024-08-14

4. Deep learning to predict rapid progression of Alzheimer’s disease from pooled clinical trials: A retrospective study;PLOS Digital Health;2024-04-10

5. Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer’s disease;Frontiers in Neurology;2024-03-06